In the last week, BIVDA have provided submissions to the Treasury ahead of the Budget on the 26th November and to the Commons' Science, Innovation and Technology Committee for their emergency inquiry into life sciences investment in the UK. The latter was prompted by high-profile withdrawals from the UK's life science sphere, notably Merck's recent decision to scrap a £1bn…
Ben KempOctober 21, 2025


